Suppression of Inflammatory Cardiac Cytokine Network in Rats with Untreated Obesity and Pre-Diabetes by AT2 Receptor Agonist NP-6A4
Obesity affects over 42% of the United States population and exacerbates heart disease, the leading cause of death in men and women. Obesity also increases pro-inflammatory cytokines that cause chronic tissue damage to vital organs. The standard-of-care does not sufficiently attenuate these inflamma...
Main Authors: | Madhavi P. Gavini, Abuzar Mahmood, Anthony M. Belenchia, Paige Beauparlant, Senthil A. Kumar, Sivakumar Ardhanari, Vincent G. DeMarco, Lakshmi Pulakat |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-06-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.693167/full |
Similar Items
-
Cell-Specific Protective Signaling Induced by the Novel AT2R-Agonist NP-6A4 on Human Endothelial and Smooth Muscle Cells
by: Ryan Toedebusch, et al.
Published: (2018-08-01) -
Differential Effects of β-Blockers, Angiotensin II Receptor Blockers, and a Novel AT2R Agonist NP-6A4 on Stress Response of Nutrient-Starved Cardiovascular Cells.
by: Abuzar Mahmood, et al.
Published: (2015-01-01) -
Diabetic Cardiomyopathy: Impact of Biological Sex on Disease Development and Molecular Signatures
by: Ryan Toedebusch, et al.
Published: (2018-05-01) -
Differential Regulation of Cardiac Function and Intracardiac Cytokines by Rapamycin in Healthy and Diabetic Rats
by: Christian Luck, et al.
Published: (2017-01-01) -
Comparison of Cardiac miRNA Transcriptomes Induced by Diabetes and Rapamycin Treatment and Identification of a Rapamycin-Associated Cardiac MicroRNA Signature
by: Anthony M. Belenchia, et al.
Published: (2018-01-01)